IRS2 - insulin receptor substrate 2 Gene
Also Known as IRS-2
Species: Homo sapiens
About IRS2
This gene has 1 transcript (splice variant), 252 orthologues, 2 paralogues and is associated with 1 phenotype. Broad expression in bone marrow (RPKM 24.6), fat (RPKM 23.1) and 23 other tissues.
Summary
This gene encodes the Insulin Receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of Insulin, insulin-like growth factor 1, and Other cytokines by acting as a molecular adaptor between diverse Receptor Tyrosine Kinases and downstream effectors. The product of this gene is phosphorylated by the Insulin Receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment. [provided by RefSeq, Jul 2008]
IRS2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_003749.3 | NP_003740.2 | insulin receptor substrate 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
15161933 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in cellular response to insulin stimulus |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
| involved in negative regulation of long-chain fatty acid import across plasma membrane |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
| involved in positive regulation of D-glucose import |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
| involved in positive regulation of fatty acid beta-oxidation |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
| involved in positive regulation of glucose metabolic process |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
| involved in positive regulation of glycogen biosynthetic process |
IMP
IMP: Inferred from mutant phenotype
|
16814735 | GOA |
IRS2 Protein Structure
PH: PH domain (32 - 143)
IRS: PTB domain (IRS-1 type) (195 - 296)
- 0
- 300
- 600
- 900
- 1200
- 1338 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
insulin receptor substrate 2 |
|
IRS2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
IRS2 | Q9Y4H2 | YWHAZ | Homo sapiens | P63104 | 15161933 | |
|
Intra
|
IRS2 | Q9Y4H2 | PIK3R1 | Homo sapiens | P27986 | 23617393 |
IRS2 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P82526 | IRS2 Antibody (YA2271) | WB, IHC-P, ICC/IF, FC | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Type 2 Diabetes Mellitus |
|
|
| Fatty Liver Disease |
|
|
| Polycystic Ovary Syndrome |
|
|
| Gestational Diabetes |
|
|
| Liver Disease |
|
|
| Hyperglycemia |
|
|
| Hyperinsulinism |
|
|
| Insulin-Like Growth Factor I |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Donohue Syndrome |
|
|
| Leptin Deficiency Or Dysfunction |
|
|
| Diabetes Mellitus |
|
|
| Breast Cancer |
|
|
| Colorectal Cancer |
|
|
| Pancreatic Cancer |
|
|
| Osteoporosis |
|
|
| Inflammatory Bowel Disease |
|
|
| Maturity-Onset Diabetes Of The Young |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | IRS2 | VGNC | VGNC:102234 |
| Rattus norvegicus | IRS2 | RGD | RGD:69316 |
| Bos taurus | IRS2 | VGNC | VGNC:30284 |
| Mus musculus | IRS2 | MGD | MGI:109334 |
| Canis familiaris | IRS2 | VGNC | VGNC:42099 |
| Macaca mulatta | IRS2 | VGNC | VGNC:82164 |
| Others | IRS2 | NCBI |